# FDA 483 - Aaron C. Ermel, MD - September 12, 2025

Source: https://www.globalkeysolutions.net/records/483/aaron-c-ermel-md/7010767b-3ec1-4b12-8272-09b626020591

> FDA 483 for Aaron C. Ermel, MD on September 12, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aaron C. Ermel, MD
- Inspection Date: 2025-09-12
- Product Type: drugs
- Office Name: Detroit District Office
- Summary: An FDA inspection of Aaron C. Ermel, MD, a clinical investigator in Indianapolis, IN, revealed a significant deviation from an investigational plan. A subject was improperly randomized and dosed despite meeting an exclusion criterion, indicating a failure to follow study protocol.

## Related Officers

- [Victoria R. Flournoy](https://www.globalkeysolutions.net/people/victoria-r-flournoy/f8bdf401-7e11-4706-9d36-d8eab4fe46ff)

Company: https://www.globalkeysolutions.net/companies/aaron-c-ermel-md/dfd4ce54-fdc6-4abc-9b98-4b29e8af1a4d

Office: https://www.globalkeysolutions.net/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03